Anti-angiogenic treatment of endometriosis: biochemical aspects.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D018450:Disease Progression; D004715:Endometriosis / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D009389:Neovascularization, Pathologic / Q000503:physiopathology / Q000517:prevention & control*; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000502:physiology
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A